For an updated list of publications please click on the following link: http://www.ncbi.nlm.nih.gov/pubmed/?term=akova+m 1: Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J; DALI Study Authors. DALI: Defining Antibiotic Levels in Intensive care unit patients: Are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014 Jan 14. [Epub ahead of print] PubMed PMID: 24429437. 2: Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, Akova M; the Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2013 Dec 24. pii: S0163-4453(13)00382-4. doi: 10.1016/j.jinf.2013.12.006. [Epub ahead of print] PubMed PMID: 24370562. 3: Averbuch D, Cordonnier C, Livermore DM, Mikulska M, Orasch C, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica. 2013 Dec;98(12):1836-47. doi: 10.3324/haematol.2013.091330. PubMed PMID: 24323984; PubMed Central PMCID: PMC3856958. 4: Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013 Dec;98(12):1826-35. doi: 10.3324/haematol.2013.091025. PubMed PMID: 24323983; PubMed Central PMCID: PMC3856957. 5: Petrosillo N, Giannella M, Antonelli M, Antonini M, Barsic B, Belancic L, Inkaya A C, De Pascale G, Grilli E, Tumbarello M, Akova M. Clinical experience of colistin-glycopeptide combination in critically ill patients infected with gram-negative bacteria. Antimicrob Agents Chemother. 2014 Feb;58(2):851-8. doi: 10.1128/AAC.00871-13. Epub 2013 Nov 25. PubMed PMID: 24277037. 6: Ben-Ami R, Halaburda K, Klyasova G, Metan G, Torosian T, Akova M. A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease. J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii25-33. doi: 10.1093/jac/dkt390. PubMed PMID: 24155143. 7: Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O; The ESCMID EFISG study group and ECMM, Arikan-Akdagli S, Cuenca-Estrella M, Dannaoui E, van Diepeningen AD, Groll AH, Guarro J, Guinea J, Hope W, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Meletiadis J, Munoz P, Pagano L, Richardson MD, Roilides E, Tortorano AM, Ullmann AJ. ESCMID/ECMM Joint Clinical Guideline for the Diagnosis and Management of Rare Invasive Yeast Infections. Clin Microbiol Infect. 2013 Sep 18. doi: 10.1111/1469-0691.12360. [Epub ahead of print] PubMed PMID: 24102785. 8: Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, de Bock R, Paesmans M, Viscoli C, Calandra T. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV. J Clin Oncol. 2013 Mar 20;31(9):1149-56. doi: 10.1200/JCO.2012.45.8109. Epub 2013 Jan 28. PubMed PMID: 23358983. 9: Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Meersseman W, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect. 2012 Dec;18 Suppl 7:68-77. doi: 10.1111/1469-0691.12042. PubMed PMID: 23137138. 10: Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Donnelly JP, Garbino J, Groll AH, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Cuenca-Estrella M; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect. 2012 Dec;18 Suppl 7:53-67. doi: 10.1111/1469-0691.12041. PubMed PMID: 23137137. 11: Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Herbrecht R, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012 Dec;18 Suppl 7:38-52. doi: 10.1111/1469-0691.12040. PubMed PMID: 23137136. 12: Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37. doi: 10.1111/1469-0691.12039. PubMed PMID: 23137135. 13: Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect. 2012 Dec;18 Suppl 7:9-18. doi: 10.1111/1469-0691.12038. PubMed PMID: 23137134. 14: Ullmann AJ, Cornely OA, Donnelly JP, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Cuenca-Estrella M; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect. 2012 Dec;18 Suppl 7:1-8. doi: 10.1111/1469-0691.12037. PubMed PMID: 23137133. 15: Erdem H, Akova M. Leading infectious diseases problems in Turkey. Clin Microbiol Infect. 2012 Nov;18(11):1056-67. doi: 10.1111/1469-0691.12000. Epub 2012 Oct 8. Review. PubMed PMID: 23043613. 16: Carlet J, Rambaud C, Pulcini C; l'Alliance contre développement des bactéries multirésistantes (ACdeBMR). [Alliance against MDRO: safeguarding antibiotics]. Ann Fr Anesth Reanim. 2012 Sep;31(9):704-8. doi: 10.1016/j.annfar.2012.07.003. Epub 2012 Aug 24. French. PubMed PMID: 22925945. 17: Finch RG, Blasi FB, Verheij TJ, Goossens H, Coenen S, Loens K, Rohde G, Saenz H, Akova M. GRACE and the development of an education and training curriculum. Clin Microbiol Infect. 2012 Sep;18(9):E308-13. doi: 10.1111/j.1469-0691.2012.03909.x. Epub 2012 Jun 25. PubMed PMID: 22731501. 18: Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012 May;18(5):439-48. doi: 10.1111/j.1469-0691.2012.03823.x. Review. PubMed PMID: 22507111. 19: Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V; European Network on Carbapenemases. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2012 May;18(5):432-8. doi: 10.1111/j.1469-0691.2012.03815.x. Review. PubMed PMID: 22507110. 20: Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen Ø, Seifert H, Woodford N, Nordmann P; European Network on Carbapenemases. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012 May;18(5):413-31. doi: 10.1111/j.1469-0691.2012.03821.x. Review. PubMed PMID: 22507109. 21: Sayin-Kutlu S, Kutlu M, Ergonul O, Akalin S, Guven T, Demiroglu YZ, Acicbe O, Akova M; Occupational Infectious Diseases Study Group. Laboratory-acquired brucellosis in Turkey. J Hosp Infect. 2012 Apr;80(4):326-30. doi: 10.1016/j.jhin.2011.12.020. Epub 2012 Feb 25. PubMed PMID: 22365915. 22: Pulcini C, Bush K, Craig WA, Frimodt-Møller N, Grayson ML, Mouton JW, Turnidge J, Harbarth S, Gyssens IC; ESCMID Study Group for Antibiotic Policies. Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis. 2012 Jan 15;54(2):268-74. doi: 10.1093/cid/cir838. Review. PubMed PMID: 22198992. 23: Gülmez D, Alp S, Topeli İskit A, Akova M, Hasçelik G. [Pneumonia caused by Fusobacterium necrophorum: is Lemierre syndrome still current?]. Mikrobiyol Bul. 2011 Oct;45(4):729-34. Turkish. PubMed PMID: 22090304. 24: Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Muñoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun Ö, Vandewoude K, Vincent JL, Donnelly JP. European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect. 2011 Sep;17 Suppl 5:1-12. doi: 10.1111/j.1469-0691.2011.03615.x. PubMed PMID: 21884296. 25: Korten V, Söyletir G, Yalçın AN, Oğünç D, Dokuzoğuz B, Esener H, Ulusoy S, Tünger A, Aygen B, Sümerkan B, Arman D, Dizbay M, Akova M, Hasçelik G, Eraksoy H, Başaran S, Köksal I, Bayramoğlu G, Akalın H, Sınırtaş M. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study]. Mikrobiyol Bul. 2011 Apr;45(2):197-209. Turkish. PubMed PMID: 21644063. 26: Nordmann P, Picazo JJ, Mutters R, Korten V, Quintana A, Laeuffer JM, Seak JC, Flamm RK, Morrissey I; COMPACT study group. Comparative activity of carbapenem testing: the COMPACT study. J Antimicrob Chemother. 2011 May;66(5):1070-8. doi: 10.1093/jac/dkr056. Epub 2011 Mar 8. PubMed PMID: 21393160. 27: Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011 Dec;17(12):1859-67. doi: 10.1111/j.1469-0691.2010.03456.x. Epub 2011 Jul 1. PubMed PMID: 21199154. 28: Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i5-14. doi: 10.1093/jac/dkq437. Review. PubMed PMID: 21177404. 29: Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C; Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14(6):R222. doi: 10.1186/cc9365. Epub 2010 Dec 8. Review. PubMed PMID: 21143834; PubMed Central PMCID: PMC3219989. 30: Kan B, Altay MA, Taşar F, Akova M. Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate. Lasers Med Sci. 2011 Sep;26(5):569-75. doi: 10.1007/s10103-010-0816-7. Epub 2010 Jul 29. PubMed PMID: 20669038. 31: Maertens J, Marchetti O, Herbrecht R, Cornely OA, Flückiger U, Frêre P, Gachot B, Heinz WJ, Lass-Flörl C, Ribaud P, Thiebaut A, Cordonnier C; Third European Conference on Infections in Leukemia. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant. 2011 May;46(5):709-18. doi: 10.1038/bmt.2010.175. Epub 2010 Jul 26. PubMed PMID: 20661235. 32: Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, Rossolini GM, Souli M, Giamarellou H. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect. 2010 Feb;16(2):102-11. doi: 10.1111/j.1469-0691.2009.03115.x. Review. PubMed PMID: 20085604. 33: Engelhard D, Akova M, Boeckh MJ, Freifeld A, Sepkowitz K, Viscoli C, Wade J, Raad I; Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Disease Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Diseases Canada; Centers for Disease Control and Prevention. Bacterial infection prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009 Oct;44(8):467-70. doi: 10.1038/bmt.2009.257. PubMed PMID: 19861980. 34: Purnak T, Beyazit Y, Sahin GO, Shorbagi A, Akova M. A novel fungal pathogen under the spotlight--Acremonium spp. associated fungaemia in an immunocompetent host. Mycoses. 2011 Jan;54(1):78-80. doi: 10.1111/j.1439-0507.2009.01762.x. PubMed PMID: 19702621. 35: Zarakolu P, Metan G, Hasçelik G, Akova M. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures]. Mikrobiyol Bul. 2007 Oct;41(4):579-84. Turkish. PubMed PMID: 18173077. 36: Akova M. Sulbactam-containing beta-lactamase inhibitor combinations. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:185-8. Review. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4. PubMed PMID: 18154545. 37: Zarakolu P, Metan G, Gürkan Aydin N, Altun B, Hasçelik G, Akova M. [The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates of Pseudomonas aeruginosa]. Mikrobiyol Bul. 2007 Jul;41(3):363-7. Turkish. PubMed PMID: 17933246. 38: Kucukardali Y, Oncul O, Cavuslu S, Danaci M, Calangu S, Erdem H, Topcu AW, Adibelli Z, Akova M, Karaali EA, Ozel AM, Bolaman Z, Caka B, Cetin B, Coban E, Karabay O, Karakoc C, Karan MA, Korkmaz S, Sahin GO, Pahsa A, Sirmatel F, Solmazgul E, Ozmen N, Tokatli I, Uzun C, Yakupoglu G, Besirbellioglu BA, Gul HC; Fever of Unknown Origin Study Group. The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study. Int J Infect Dis. 2008 Jan;12(1):71-9. Epub 2007 Jul 12. PubMed PMID: 17629532. 39: Cornaglia G, Akova M, Amicosante G, Cantón R, Cauda R, Docquier JD, Edelstein M, Frère JM, Fuzi M, Galleni M, Giamarellou H, Gniadkowski M, Koncan R, Libisch B, Luzzaro F, Miriagou V, Navarro F, Nordmann P, Pagani L, Peixe L, Poirel L, Souli M, Tacconelli E, Vatopoulos A, Rossolini GM; ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS). Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents. 2007 Apr;29(4):380-8. Epub 2007 Jan 16. PubMed PMID: 17223319. 40: Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T. Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894. PubMed PMID: 16983616. 41: Metan G, Zarakolu P, Hasçelik G, Akova M. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates]. Mikrobiyol Bul. 2006 Jan-Apr;40(1-2):23-8. Turkish. PubMed PMID: 16775953. 42: Sahin GO, Akova M. Treatment of invasive infections due to rare or emerging yeasts and moulds. Expert Opin Pharmacother. 2006 Jun;7(9):1181-90. Review. PubMed PMID: 16732704. 43: Elcin M, Odabasi O, Gokler B, Sayek I, Akova M, Kiper N. Developing and evaluating professionalism. Med Teach. 2006 Feb;28(1):36-9. PubMed PMID: 16627321. 44: Pannek S, Higgins PG, Steinke P, Jonas D, Akova M, Bohnert JA, Seifert H, Kern WV. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. J Antimicrob Chemother. 2006 May;57(5):970-4. Epub 2006 Mar 10. PubMed PMID: 16531429. 45: Zarakolu P, Metan G, Hasçelik G, Akova M. [Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains]. Mikrobiyol Bul. 2005 Jul;39(3):265-72. Turkish. PubMed PMID: 16358485. 46: Schumacher A, Steinke P, Bohnert JA, Akova M, Jonas D, Kern WV. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother. 2006 Feb;57(2):344-8. Epub 2005 Dec 14. PubMed PMID: 16354746. 47: Gülkesen KH, Akan H, Akova M, Calıkoğlu T. Log analysis of a Turkish web portal; febrile neutropenia. Stud Health Technol Inform. 2005;116:873-8. PubMed PMID: 16160368. 48: Akova M. Clinical microbiology and infectious diseases - 11th European Congress. 1-4 April 2001, Istanbul, Turkey. IDrugs. 2001 Jul;4(7):737-41. PubMed PMID: 15995922. 49: Guven GS, Uzun O, Cakir B, Akova M, Unal S. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001). Support Care Cancer. 2006 Jan;14(1):52-5. Epub 2005 Jun 10. PubMed PMID: 15947955. 50: Soylu AR, Dökmeci G, Tezel A, Umit H, Amuca H, Akova M, Türe M, Bayraktar Y. Predictors of short-term outcome of spontaneous bacterial peritonitis in Turkish cirrhotic patients. J Gastroenterol Hepatol. 2005 Apr;20(4):657-60. PubMed PMID: 15836724. 51: Akova M, Paesmans M, Calandra T, Viscoli C; International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer. Clin Infect Dis. 2005 Jan 15;40(2):239-45. Epub 2004 Dec 20. PubMed PMID: 15655741. 52: Akova M. Clinical microbiology and infectious disease -- 14th European conference. IDrugs. 2004 Jun;7(6):520-4. PubMed PMID: 15197650. 53: Oude Lashof AM, De Bock R, Herbrecht R, de Pauw BE, Krcmery V, Aoun M, Akova M, Cohen J, Siffnerová H, Egyed M, Ellis M, Marinus A, Sylvester R, Kullberg BJ; EORTC Invasive Fungal Infections Group. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. Eur J Cancer. 2004 Jun;40(9):1314-9. PubMed PMID: 15177489. 54: Harmanci A, Harmanci O, Akova M. Hospital-acquired pneumonia: challenges and options for diagnosis and treatment. J Hosp Infect. 2002 Jul;51(3):160-7. Review. PubMed PMID: 12144794. 55: Kocagöz S, Akova M, Altun B, Gür D, Hasçelik G. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infect. 2002 Apr;8(4):240-2. PubMed PMID: 12047416. 56: Akova M. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors. Int J Clin Pract Suppl. 2002 Mar;(125):19-27; discussion 37-9. Review. PubMed PMID: 12014853. 57: Erman M, Akova M, Akan H, Korten V, Ferhanoğlu B, Köksal I, Cetinkaya Y, Uzun O, Unal S; Febrile Neutropenia Study Group of Turkey. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study. Scand J Infect Dis. 2001;33(11):827-31. PubMed PMID: 11760163. 58: Cetinkaya Y, Akova M, Akalin HE, Aşçioğlu S, Hayran M, Uzuns O, Aksöyek S, Tokgözoğlu L, Oto A, Kes S, Paşaoğlu I, Unal S. A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common. Int J Antimicrob Agents. 2001 Jul;18(1):1-7. PubMed PMID: 11463520. 59: Köseoğlu O, Kocagöz S, Gür D, Akova M. Nosocomial bloodstream infections in a Turkish university hospital: study of Gram-negative bacilli and their sensitivity patterns. Int J Antimicrob Agents. 2001 Jun;17(6):477-81. PubMed PMID: 11397618. 60: Eldem T, Arican-Cellat N, Agabeyoglu I, Akova M, Kansu E. Pharmacokinetics of liposomal amphotericin B in neutropenic cancer patients. Int J Pharm. 2001 Feb 1;213(1-2):153-61. PubMed PMID: 11165103. 61: Cetinkaya Y, Kocagöz S, Hayran M, Uzun O, Akova M, Gürsu G, Unal S. Analysis of a mini-outbreak of methicillin-resistant Staphylococcus aureus in a surgical ward by using arbitrarily primed-polymerase chain reaction. J Chemother. 2000 Apr;12(2):138-44. PubMed PMID: 10789553. 62: Gür D, Kocagöz S, Akova M, Unal S. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis. Antimicrob Agents Chemother. 1999 Sep;43(9):2337. PubMed PMID: 10577353; PubMed Central PMCID: PMC89478. 63: Akova M, Akan H, Korten V, Biberoğlu K, Hayran M, Unal S, Kars A, Kansu E. Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey. Int J Antimicrob Agents. 1999 Sep;13(1):15-9. PubMed PMID: 10563400. 64: Oge O, Ozen H, Oner S, Akova M, Bilen CY. Occupational risk of hepatitis B and C infections in urologists. Urol Int. 1998;61(4):206-9. PubMed PMID: 10364750. 65: Akova M, Gür D, Livermore DM, Kocagöz T, Akalin HE. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob Agents Chemother. 1999 May;43(5):1298-300. PubMed PMID: 10223958; PubMed Central PMCID: PMC89265. 66: Akan H, Akova M, Ataoğlu H, Aksu G, Arslan O, Koç H. Rhodococcus equi and Nocardia brasiliensis infection of the brain and liver in a patient with acute nonlymphoblastic leukemia. Eur J Clin Microbiol Infect Dis. 1998 Oct;17(10):737-9. PubMed PMID: 9865991. 67: Arikan S, Uzun O, Cetinkaya Y, Kocagöz S, Akova M, Unal S. Primary cutaneous aspergillosis in human immunodeficiency virus-infected patients: two cases and review. Clin Infect Dis. 1998 Sep;27(3):641-3. Review. PubMed PMID: 9770168. 68: Arikan S, Akova M, Hayran M, Ozdemir O, Erman M, Gür D, Unal S. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis. Clin Infect Dis. 1998 Apr;26(4):903-8. PubMed PMID: 9564473. 69: Arikan S, Gür D, Akova M. Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients. Mycoses. 1997 Nov;40(7-8):291-6. PubMed PMID: 9476512. 70: Tuncer S, Hayran M, Akan O, Gür D, Akova M, Unal S. Native valve endocarditis with persistent embolization due to Neisseria mucosa. Clin Microbiol Infect. 1997 Feb;3(1):137-139. PubMed PMID: 11864091. 71: Unal S, Hayran M, Tuncer S, Gür D, Uzun O, Akova M, Akalin HE. Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial. Antimicrob Agents Chemother. 1996 Dec;40(12):2898-900. PubMed PMID: 9124864; PubMed Central PMCID: PMC163645. 72: Akova M, Ozcebe O, Güllü I, Unal S, Gür D, Akalin S, Tokgözoglu M, Telatar F, Akalin HE. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections. J Chemother. 1996 Aug;8(4):284-9. PubMed PMID: 8873834. 73: Bayraktar Y, Arslan S, Sivri B, Eryilmaz M, Akova M, Van Thiel DH, Kayhan B. Percutaneous drainage of hepatic abscesses: therapy does not differ for those with identifiable biliary fistula. Hepatogastroenterology. 1996 May-Jun;43(9):620-6. PubMed PMID: 8799406. 74: Barista I, Celik I, Güllü I, Hayran M, Akova M. Integrating the time factor into the definition of metastasis of unknown origin. J Natl Cancer Inst. 1996 Jan 3;88(1):51. PubMed PMID: 8847726. 75: Akova M, Akalin HE, Uzun O, Hayran M, Tekuzman G, Kansu E, Aslan S, Telatar H. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome. Clin Infect Dis. 1994 Mar;18(3):298-304. PubMed PMID: 8011807. 76: Uzun O, Hayran M, Akova M, Gür D, Akalin HE. Efficacy of a three-day course of azithromycin in the treatment of community-acquired pneumococcal pneumonia. Preliminary report. J Chemother. 1994 Feb;6(1):53-7. PubMed PMID: 8071680. 77: Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gür D. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother. 1993 Sep;37(9):1831-4. PubMed PMID: 8239591; PubMed Central PMCID: PMC188077. 78: Hall LM, Livermore DM, Gur D, Akova M, Akalin HE. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1993 Aug;37(8):1637-44. PubMed PMID: 8215276; PubMed Central PMCID: PMC188033. 79: Akova M, Akalìn HE, Korten V, Ozgen T, Erbengi A. Treatment of intracranial abscesses: experience with sulbactam/ampicillin. J Chemother. 1993 Jun;5(3):181-5. PubMed PMID: 8371128. 80: Akova M, Bonfiglio G, Livermore DM. Susceptibility to beta-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 beta-lactamases. J Med Microbiol. 1991 Oct;35(4):208-13. PubMed PMID: 1941990. 81: Akova M, Akalin HE, Uzun O, Gür D. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis. 1991 Jul;10(7):598-9. PubMed PMID: 1915408. 82: Akova M, Yang Y, Livermore DM. Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases. J Antimicrob Chemother. 1990 Feb;25(2):199-208. PubMed PMID: 2158496. 83: Livermore DM, Akova M, Wu PJ, Yang YJ. Clavulanate and beta-lactamase induction. J Antimicrob Chemother. 1989 Nov;24 Suppl B:23-33. PubMed PMID: 2606817.

Infections in immunoompromised host and in patients with cancer

High School	PERTEVNİYAL LİSESİ 1976
University	İSTANBUL ÜNİVERSİTESİ İSTANBUL TIP FAKÜLTESİ 1982
Academic Background	Master / HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ İÇ HASTALIKLARI 1989 Postgraduate / HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ İNFEKSİYON HASTALIKLARI 1991
Foreign Experience / Education	1988-1989 The London Hospital Medical College, Department of Medical Microbiology, London, UK 1992-1993 Tufts University, School of Medicine, Center for Adaptive Resistance and Microbiology, Boston, USA
Foreign Language	English

:

: